Eva N. Hamulyák

Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial

Siobhan Quenby, Katie Booth, Louise Hiller et al. · The Lancet · 2023 · 68 citations · Full text

Thrombosis, Venous Thrombosis, Postpartum Hemorrhage +9

Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer

Giancarlo Agnelli, Andrés J. Muñoz Martín, Laura Franco et al. · Thrombosis and Haemostasis · 2021 · 50 citations · Full text

Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases

Avi Leader, Eva N. Hamulyák, Brian J. Carney et al. · Blood Advances · 2020 · 47 citations · Full text

Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate

Roisin Bavalia, Rahat A. Abdoellakhan, Herm Jan M. Brinkman et al. · Research and Practice in Thrombosis and Haemostasis · 2020 · 25 citations · Full text

Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study

Eva N. Hamulyák, Hanke M.G. Wiegers, Luuk J.J. Scheres et al. · Research and Practice in Thrombosis and Haemostasis · 2020 · 15 citations · Full text